Comparação do uso de noradrenalina, nitroprussiato e levosimendan na terapia do choque hipovolêmico: efeitos sobre a microcirculação e expressão gênica renal

• Autor(a) principal: Lima, Ronald de Albuquerque
• Data de Publicação: 2014
• Tipo de documento: Tese
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações da UERJ
• Texto Completo: http://www.bdtd.uerj.br/handle/1/12644
• topic: Cardiovascular pathophysiology; Microcirculation; Dorsal chambre; Hemorrhagic shock; Cardiovascular pharmacology; Sangue Circulação; Microcirculação; Choque hemorrágico; Noradrenalina; Fisiopatologia cardiovascular; Microcirculação; Câmara dorsal; Choque hemorrágico; Farmacologia cardiovascular; CNPQ::CIENCIAS BIOLOGICAS::FISIOLOGIA::FISIOLOGIA DE ORGAOS E SISTEMAS::FISIOLOGIA CARDIOVASCULAR

This work aimed at evaluating the systemic and microcirculatory effects, as well as changes in renal gene expression elicited by noradrenalin, sodium nitroprusside and levosimendan associated to volume resuscitation in the treatment of hemorrhagic shock. The dorsal chamber model was used in this study. Animals were subjected to hemorrhagic shock and after that, were randomly distributed between four groups. Groups were: CTRL, received only lactated ringer's solution; NPS received lactated ringer's solution with sodium nitroprusside; NA received lactated ringer's solution with noradrenaline and LEV received lactated ringer's with levosimendan. Systemic and microcirculatory parameters were evaluated ( as percent change compared to baseline). Furthermore, renal genic expression of eNOS, HIF-1a and caspase-3 were also evaluated. NPS group presented a sustained recovery of arteriolar diameter ( 89± 12 %) and FCD (125 ±114 %) at the end of the treatment. There was a red blood cell velocity recovery in CTRL and NPS groups. There was no difference regarding adhered or rolling leukocytes at the end of the treatment. eNOS and caspase-3 renal genic expression between groups showed no differences, however, there was a significant difference in renal genic expression of HIF-1α in NA group (0,65 ± 0,08, AU) compared to CTRL (0,44 ± 0,06, AU) e LEV (0,45 ± 0,06, AU). All groups had a higher expression of ICAM (0,65 ± 0,12; 0,7 ± 0,12; 0,069 ± 0,06; 0,65 ± 0,12, AU) compared to the SHAM group (0,50 ± 0,05, AU). Ringer's lactate solution associated or not to noradrenaline or levosimendan were not enough to recover and sustain microvascular parameters. Treatment with sodium nitroprusside presented the best results, with sustained arteriolar diameter, FCD and RBCV recoveries.